US Drug Recall Register
Class I · High risk Terminated Initiated Oct 19, 2021 (5 years ago)

Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Identified as Glass Particles

What was recalled

Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01

Recalling firm
Merck Sharp & Dohme CORP
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0093-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Daptomycin recalls

See all